[Cutaneous Rosai-Dorfman syndrome. Successful therapy with intrralesional corticosteroids]

Hautarzt. 2014 Aug;65(8):725-7. doi: 10.1007/s00105-014-2797-0.
[Article in German]

Abstract

Background: Cutaneous Rosai-Dorfman disease is a rare disorder belonging to the spectrum of non-Langerhans cell histiocytoses. It is characterized by dermal and subcutaneous infiltrates of histiocytes as well as accompanying lymphocytes, plasma cells and granulocytes. Because it is so rare, standard therapies have not been established.

Case report: A 27-year-old man showed an excellent response to intralesional corticosteroids after unsuccessful prior treatment with methotrexate, systemic steroids and surgery as well as laser therapy.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage*
  • Adult
  • Dermatitis / drug therapy*
  • Dermatitis / pathology*
  • Histiocytosis, Sinus / drug therapy*
  • Histiocytosis, Sinus / pathology*
  • Humans
  • Injections, Intralesional
  • Male
  • Syndrome
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones